(C001) Lyxor Core DAX (DR) - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0378438732
C001: Stocks, Shares, Equity, Investments, Assets
The Lyxor Core DAX (DR) UCITS ETF (XETRA:C001) is a UCITS-compliant exchange-traded fund designed to track the performance of the Morningstar Germany TME NR EUR Index. This index is a market-capitalization-weighted representation of German equities, providing exposure to key sectors of the German economy.
From a technical perspective, the ETF shows an average daily trading volume of 12,014 shares over the past 20 days, indicating moderate liquidity. The last price of 176.72 EUR reflects current market valuation. The short-term SMA (20-day) stands at 163.88, while the medium-term SMA (50-day) is 170.04, and the long-term SMA (200-day) is 154.80. These metrics suggest a recent upward trend in the ETFs price movement. The ATR of 3.93 indicates moderate volatility, with price fluctuations averaging 3.93 EUR over the past 20 days.
Fundamentally, the ETF manages Assets Under Management (AUM) of 1,058.54 million EUR, highlighting its scale and investor interest. This AUM level typically corresponds to higher liquidity and tighter bid-ask spreads, making it attractive for both retail and institutional investors seeking exposure to German equities.
Based on the technical and fundamental data, the ETF is expected to maintain its upward momentum in the short term, supported by the positive SMA crossover and moderate trading volume. However, market sentiment and broader economic conditions in Germany will remain key drivers of its performance. Investors should monitor macroeconomic indicators, corporate earnings, and geopolitical developments that could impact the German equity market.
Additional Sources for C001 ETF
C001 ETF Overview
Market Cap in USD | 1,221m |
Category | Germany Equity |
TER | 0.08% |
IPO / Inception | 2023-12-07 |
C001 ETF Ratings
Growth Rating | 76.7 |
Fundamental | - |
Dividend Rating | 51.5 |
Rel. Strength | 0.08 |
Analysts | - |
Fair Price Momentum | 187.91 EUR |
Fair Price DCF | - |
C001 Dividends
Dividend Yield 12m | 1.99% |
Yield on Cost 5y | 3.55% |
Annual Growth 5y | 3.33% |
Payout Consistency | 92.8% |
Payout Ratio | % |
C001 Growth Ratios
Growth Correlation 3m | 72.9% |
Growth Correlation 12m | 95.3% |
Growth Correlation 5y | 79.5% |
CAGR 5y | 13.75% |
CAGR/Max DD 5y | 0.52 |
Sharpe Ratio 12m | 1.93 |
Alpha | 20.72 |
Beta | 0.568 |
Volatility | 12.47% |
Current Volume | 17.6k |
Average Volume 20d | 8.1k |
As of June 16, 2025, the stock is trading at EUR 179.56 with a total of 17,585 shares traded.
Over the past week, the price has changed by -2.71%, over one month by -0.83%, over three months by +1.23% and over the past year by +29.56%.
Yes. Based on ValueRay´s Analyses, Lyxor Core DAX (DR) (XETRA:C001) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 76.71 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of C001 is around 187.91 EUR . This means that C001 is currently overvalued and has a potential downside of 4.65%.
Lyxor Core DAX (DR) has no consensus analysts rating.
According to our own proprietary Forecast Model, C001 Lyxor Core DAX (DR) will be worth about 209 in June 2026. The stock is currently trading at 179.56. This means that the stock has a potential upside of +16.4%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 209 | 16.4% |